Details

Ergodične lastnosti translacijsko invariantnih verig Majorana fermionov : magistrsko delo
ID Klobas, Katja (Author), ID Prosen, Tomaž (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (1,44 MB)
MD5: CF86630EE4465B5AA19172C72129DD2C
PID: 20.500.12556/rul/ccad3037-c8f7-4bb3-b123-ca8a8b75d0f7

Language:Slovenian
Keywords:Majorana fermioni, kvantna ergodičnost, modeli spinskih verig, Floquetovi sistemi
Work type:Master's thesis/paper
Typology:2.09 - Master's Thesis
Organization:FMF - Faculty of Mathematics and Physics
Place of publishing:Ljubljana
Publisher:[K. Klobas]
Year:2016
Number of pages:53 str.
PID:20.500.12556/RUL-97374 This link opens in a new window
UDC:536.931:530.145
COBISS.SI-ID:3008100 This link opens in a new window
Publication date in RUL:24.10.2017
Views:1961
Downloads:464
Metadata:XML DC-XML DC-RDF
:
KLOBAS, Katja, 2016, Ergodične lastnosti translacijsko invariantnih verig Majorana fermionov : magistrsko delo [online]. Master’s thesis. Ljubljana : K. Klobas. [Accessed 26 June 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=97374
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Keywords:Majorana fermions, quantum ergodicity, spin chain models, Floquet systems

Similar documents

Similar works from RUL:
  1. ǂA ǂswimwear collection aimed towards people with multiple sclerosis
  2. Dietary behaviors of patients with multiple sclerosis
  3. Izobraževanje oseb z multiplo sklerozo
  4. Sexual disorders and their impact on quality of life in persons with multiple sclerosis
  5. ǂThe ǂeffect of yoga on quality of life of adult asthmatics
Similar works from other Slovenian collections:
  1. Physiotherapeutical treatment of patients with multiple sclerosis
  2. QUALITY OF LIFE IN PATIENTS WITH MULTIPLE SCLEROSIS
  3. Impact of physiotherapy on the rehabilitation of persons with multiple sclerosis
  4. Kakovost življenja bolnikov z multiplo sklerozo po uvedbi zdravljenja z delfampridinom
  5. Predicting readmission risk for patients with multiple sclerosis

Back